Search

Author/Creator Konstantinopoulos, Panagiotis A

1. 2022-RA-687-ESGO ARTISTRY-7: phase 3, multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68). (20th October 2022)

Authors:
Herzog, Thomas J; Moore, Kathleen; Konstantinopoulos, Panagiotis A; Gilbert, Lucy; Hays, John L; Monk, Bradley J; O'Malley, David M; Barlin, Joyce N; Graham, Julie R; Desai, Monali; Wang, Yan; Du, Yangchun; Dalal, Rita; Coleman, Robert L; Sehouli, Jalid
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A255
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial. Issue 7 (July 2020)

Authors:
Konstantinopoulos, Panagiotis A; Cheng, Su-Chun; Wahner Hendrickson, Andrea E; Penson, Richard T; Schumer, Susan T; Doyle, L Austin; Lee, Elizabeth K; Kohn, Elise C; Duska, Linda R; Crispens, Marta A; Olawaiye, Alexander B; Winer, Ira S; Barroilhet, Lisa M; Fu, Siqing; McHale, Michael T; Schilder...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 7(2020)
Page Start:
957
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial. Issue 4 (April 2019)

Authors:
Konstantinopoulos, Panagiotis A; Barry, William T; Birrer, Michael; Westin, Shannon N; Cadoo, Karen A; Shapiro, Geoffrey I; Mayer, Erica L; O'Cearbhaill, Roisin E; Coleman, Robert L; Kochupurakkal, Bose; Whalen, Christin; Curtis, Jennifer; Farooq, Sarah; Luo, Weixiu; Eismann, Julia; Buss, Mary K;...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 4(2019)
Page Start:
570
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer. Issue 2 (1st October 2020)

Authors:
Friedman, Claire F; Snyder Charen, Alexandra; Zhou, Qin; Carducci, Michael A; Buckley De Meritens, Alexandre; Corr, Bradley R; Fu, Siqing; Hollmann, Travis J; Iasonos, Alexia; Konner, Jason A; Konstantinopoulos, Panagiotis A; Modesitt, Susan C; Sharon, Elad; Aghajanian, Carol; Zamarin, Dmitriy
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer. Issue 3 (14th March 2022)

Authors:
Lheureux, Stephanie; Matei, Daniela E; Konstantinopoulos, Panagiotis A; Wang, Ben X; Gadalla, Ramy; Block, Matthew S; Jewell, Andrea; Gaillard, Stephanie L; McHale, Michael; McCourt, Carolyn; Temkin, Sarah; Girda, Eugenia; Backes, Floor J; Werner, Theresa L; Duska, Linda; Kehoe, Siobhan; Colombo,...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 3(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗